Simpson Thacher represented J.P. Morgan Securities LLC, Citigroup Global Markets Inc. and UBS Securities LLC as joint bookrunners in the offering of $400 million of 11.125% Senior Notes due 2019 of IVD Acquisition Corporation, a portion of the financing for the $1.9 billion acquisition of Immucor, Inc. by affiliates of TPG Capital, L.P.~~Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor also markets a complete family of automated instrumentation for all of its market segments.~~The Simpson Thacher team included John Ericson, Dora Jimenez and Alexander Coedo (Capital Markets); Chang Won Choi (Tax); Mark Villaverde (Litigation); and Elizabeth Gillen (Intellectual Property).